Humberto Caldera

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters

Maha El-Zimaity, Rima M. Saliba, Ka‐Wah Chan et al. · Blood · 2004 · 109 citations · Full text

Radical Resection of Periampullary Tumors in the Elderly: Evaluation of Long‐term Results

Oliver F. Bathe, David Levi, Humberto Caldera et al. · World Journal of Surgery · 2000 · 75 citations

Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

Hugo F. Fernández, Hai T. Tran, Federico Albrecht et al. · Biology of Blood and Marrow Transplantation · 2002 · 66 citations · Full text

Diminished benefit from resection of cancer of the head of the pancreas in patients of advanced age

Oliver F. Bathe, Humberto Caldera, Kara L. Hamilton et al. · Journal of Surgical Oncology · 2001 · 35 citations